FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bayard Clarkson

Research Profile

Anatomy

Disorders

Chemicals & Drugs

Procedures

Physiology

Cell Divisions

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Ferdinand Rossi; Yasemin Yozgat; Elisa de Stanchina; Darren R Veach; Bayard Clarkson; Katia Manova-Todorova; Filippo G Giancotti; Cristina R Antonescu; Peter Besmer
Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.
Christophe Antczak; Darren R Veach; Christina N Ramirez; Maria A Minchenko; David Shum; Paul A Calder; Mark Frattini; Bayard Clarkson; Hakim Djaballah
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.
Tianhua Guo; Mihai Hajdu; Narasimhan P Agaram; Hiroko Shinoda; Darren R Veach; Bayard Clarkson; ROBERT G MAKI; Samuel Singer; Ronald P DeMatteo; Peter Besmer; Cristina R Antonescu
Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bayard Clarkson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Ferdinand Rossi; Yasemin Yozgat; Elisa de Stanchina; Darren R Veach; Bayard Clarkson; Katia Manova-Todorova; Filippo G Giancotti; Cristina R Antonescu; Peter Besmer
Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.
Molecular cancer research : MCR 2010;8(9):1271-83.
2009: Christophe Antczak; Darren R Veach; Christina N Ramirez; Maria A Minchenko; David Shum; Paul A Calder; Mark Frattini; Bayard Clarkson; Hakim Djaballah
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.
Bioorganic & medicinal chemistry letters 2009;19(24):6872-6.
2009: Tianhua Guo; Mihai Hajdu; Narasimhan P Agaram; Hiroko Shinoda; Darren R Veach; Bayard Clarkson; ROBERT G MAKI; Samuel Singer; Ronald P DeMatteo; Peter Besmer; Cristina R Antonescu
Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):6862-70.
2009: Jasmine Foo; Mark W Drummond; Bayard Clarkson; Tessa Holyoake; Franziska Michor
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.
PLoS computational biology 2009;5(9):e1000503.
2008: Ding Wu; Michael R Mand; Darren R Veach; Laurie L Parker; Bayard Clarkson; Stephen J Kron
A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates.
Analytical biochemistry 2008;375(1):18-26.
2007: Sizhi Paul Gao; Kevin G Mark; Kenneth Leslie; William Pao; Noriko Motoi; William L Gerald; William D Travis; William G Bornmann; Darren R Veach; Bayard Clarkson; Jacqueline F Bromberg
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
The Journal of clinical investigation 2007;117(12):3846-56.
2007: Darren R Veach; Mohammad Namavari; Nagavarakishore Pillarsetty; Elmer B Santos; Tatiana Beresten-Kochetkov; Caryl L Lambek; Blesida J Punzalan; Christophe Antczak; Peter Smith-Jones; Hakim Djaballah; Bayard Clarkson; Steven M Larson
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.
Journal of medicinal chemistry 2007;50(23):5853-7.
2007: Tianhua Guo; Narasimhan P Agaram; Grace C Wong; Glory Hom; David R D'Adamo; ROBERT G MAKI; Gary K Schwartz; Darren R Veach; Bayard Clarkson; Samuel Singer; Ronald P DeMatteo; Peter Besmer; Cristina R Antonescu
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4874-81.
2007: Cristina R Antonescu; Klaus J Busam; Todd D Francone; Grace C Wong; Tianhua Guo; Narasimhan P Agaram; Peter Besmer; Achim Jungbluth; Mark I Gimbel; Chin-Tung Chen; Darren R Veach; Bayard Clarkson; Philip B Paty; Martin R Weiser
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
International journal of cancer. Journal international du cancer 2007;121(2):257-64.
2006: Xiquan Liang; Mahbod Hajivandi; Darren R Veach; David Wisniewski; Bayard Clarkson; Marilyn D Resh; Marshall pope
Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.
Proteomics 2006;6(16):4554-64.
2006: Mohammad Azam; Valentina Nardi; William C Shakespeare; Chester A Metcalf; Regine S Bohacek; Yihan Wang; Raji Sundaramoorthi; Piotr Sliz; Darren R Veach; William G Bornmann; Bayard Clarkson; David C Dalgarno; Tomi K Sawyer; George Q Daley
Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(24):9244-9.
2006: Hans-Guido Wendel; Elisa de Stanchina; Enriqué Cepero; Sagarika Ray; Michael Emig; Jordan S Fridman; Darren R Veach; William G Bornmann; Bayard Clarkson; W Richard McCombie; Scott C Kogan; Andreas Hochhaus; Scott W Lowe
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(19):7444-9.
2005: Nicholas C Wolff; Darren R Veach; William P Tong; William G Bornmann; Bayard Clarkson; Robert L Ilaria
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.
Blood 2005;105(10):3995-4003.
2005: Darren R Veach; Mohammad Namavari; Tatiana Beresten; Julius Balatoni; Maria Minchenko; Hakim Djaballah; Ronald D Finn; Bayard Clarkson; Juri G Gelovani; William G Bornmann; Steven M Larson
Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors.
Nuclear medicine and biology 2005;32(4):313-21.
2005: Nikolas von Bubnoff; Darren R Veach; Heiko van der Kuip; Walter Aulitzky; Jana Sänger; Petra Seipel; William G Bornmann; Christian Peschel; Bayard Clarkson; Justus Duyster
A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor.
Blood 2005;105(4):1652-9.
2004: Xinzhu Deng; E Randal Hofmann; Alberto Villanueva; Oliver Hobert; Paola Capodieci; Darren R Veach; Xianglei Yin; Luis Campodonico; Athanasios Glekas; Carlos Cordon-Cardo; Bayard Clarkson; William G Bornmann; Zvi Fuks; Michael O. Hengartner; Richard Kolesnick
Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation.
Nature genetics 2004;36(8):906-12.
2003: William Netzer; Fei Dou; Dongming Cai; Darren R Veach; Stephanie Jean; Yueming Li; William G Bornmann; Bayard Clarkson; Huaxi Xu; Paul Greengard
Gleevec inhibits beta-amyloid production but not Notch cleavage.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(21):12444-9.
2003: Nikolas von Bubnoff; Darren R Veach; W Todd Miller; Wanqing Li; Jana Sänger; Christian Peschel; William G Bornmann; Bayard Clarkson; Justus Duyster
Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors.
Cancer research 2003;63(19):6395-404.
2003: Bayard Clarkson; Annabel Strife; David Wisniewski; Caryl L Lambek; Chongyuan Liu
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
Leukemia 2003;17(7):1211-62.
2003: Bhushan Nagar; Oliver Hantschel; Matthew Adam Young; Klaus Scheffzek; Darren R Veach; William G Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Structural basis for the autoinhibition of c-Abl tyrosine kinase.
Cell 2003;112(6):859-71.
2003: Annabel Strife; David Wisniewski; Chongyuan Liu; Caryl L Lambek; Zbigniew Darzynkiewicz; Richard T Silver; Bayard Clarkson
Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
Molecular cancer research : MCR 2003;1(3):176-85.
2002: David Wisniewski; Caryl L Lambek; Chongyuan Liu; Annabel Strife; Darren R Veach; Bhushan Nagar; Matthew Adam Young; Thomas Schindler; William G Bornmann; Joseph R Bertino; John Kuriyan; Bayard Clarkson
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
Cancer research 2002;62(15):4244-55.
2002: Bhushan Nagar; William G Bornmann; Patricia Pellicena; Thomas Schindler; Darren R Veach; W Todd Miller; Bayard Clarkson; John Kuriyan
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).
Cancer research 2002;62(15):4236-43.
2002: Xiquan Liang; David Wisniewski; Annabel Strife; Bayard Clarkson; Marilyn D Resh
Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.
The Journal of biological chemistry 2002;277(16):13732-8.
2002: Bayard Clarkson
Treatment of preschool OCD.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(4):363; author reply 363.
2001: Antonio Di Cristofano; Masaru Niki; Mingming Zhao; Fredrick G Karnell; Bayard Clarkson; Warren S Pear; Linda Van Aelst; Pier Paolo Pandolfi
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).
The Journal of experimental medicine 2001;194(3):275-84.
2000: Thomas Schindler; William G Bornmann; Patricia Pellicena; W Todd Miller; Bayard Clarkson; John Kuriyan
Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.
Science (New York, N.Y.) 2000;289(5486):1938-42.
2000: N M Dunant; David Wisniewski; Annabel Strife; Bayard Clarkson; Marilyn D Resh
The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
Cellular signalling 2000;12(5):317-26.
2000: Ellin Berman; Suresh C Jhanwar; M McBride; Annabel Strife; David Wisniewski; Caryl L Lambek; Bayard Clarkson
Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL).
Leukemia research 2000;24(4):289-97.
1999: David Wisniewski; Annabel Strife; S Swendeman; H Erdjument-Bromage; S Geromanos; W M Kavanaugh; Paul Tempst; Bayard Clarkson
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Blood 1999;93(8):2707-20.
1998: Antonio Di Cristofano; N Carpino; N Dunant; G Friedland; Ryuji Kobayashi; Annabel Strife; David Wisniewski; Bayard Clarkson; Pier Paolo Pandolfi; Marilyn D Resh
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.
The Journal of biological chemistry 1998;273(9):4827-30.
1997: Bayard Clarkson; Annabel Strife; David Wisniewski; Caryl L Lambek; N Carpino
New understanding of the pathogenesis of CML: a prototype of early neoplasia.
Leukemia 1997;11(9):1404-28.
1997: N Carpino; David Wisniewski; Annabel Strife; D Marshak; Ryuji Kobayashi; Bruce Stillman; Bayard Clarkson
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Cell 1997;88(2):197-204.
1996: David Wisniewski; Annabel Strife; Bayard Clarkson
c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
Leukemia 1996;10(9):1436-42.
1996: David Wisniewski; Annabel Strife; Ellin Berman; Bayard Clarkson
c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
Leukemia 1996;10(2):229-37.
1995: Bayard Clarkson; B A Chabner; Robert A. Weinberg
Targets for specific therapies in leukemia.
Cancer research 1995;55(19):4488-98.
1994: Bayard Clarkson
Specific genetic defects as targets for selective therapies. Commentary.
Current opinion in hematology 1994;1(4):235-47.
1994: Francisco Cervantes; J E Robertson; Ciril Rozman; M Baccarani; S Tura; G A Gómez; T J Braun; Bayard Clarkson; A Pereira
Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.
British journal of haematology 1994;87(2):293-300.
1994: A Tafuri; R M Lemoli; R Chen; S C Gulati; Bayard Clarkson; M Andreeff
Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Leukemia 1994;8(5):749-57.
1994: David Wisniewski; Annabel Strife; D Wojciechowicz; C Lambek; Bayard Clarkson
A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.
Leukemia 1994;8(4):688-93.
1993: Bayard Clarkson; Annabel Strife
Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
Leukemia 1993;7(11):1683-721.
1993: Annabel Strife; A Perez; C Lambek; David Wisniewski; S Bruno; Zbigniew Darzynkiewicz; Bayard Clarkson
Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand.
Leukemia research 1993;17(9):799-807.
1993: Joachim Yahalom; G Varsos; Zvi Fuks; J Myers; Bayard Clarkson; David J Straus
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study.
Cancer 1993;71(7):2342-50.
1993: Annabel Strife; A Perez; C Lambek; David Wisniewski; S Bruno; Zbigniew Darzynkiewicz; Bayard Clarkson
Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
Cancer research 1993;53(2):401-9.
1993: J Gold; D Shera; Bayard Clarkson
Private psychiatric hospitalization of children: predictors of length of stay.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32(1):135-43.
1993: Bayard Clarkson; Annabel Strife
Cytokinetic considerations relevant to development of a successful therapeutic strategy in chronic myelogenous leukemia (CML).
Leukemia & lymphoma 1993;11 Suppl 1():101-7.
1993: Bayard Clarkson; Annabel Strife; A Perez; C Lambek; David Wisniewski
Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML).
Leukemia & lymphoma 1993;11 Suppl 2():81-100.
1992: R M Lemoli; Annabel Strife; Bayard Clarkson; J D Haley; S C Gulati
TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
Experimental hematology 1992;20(11):1252-6.
1992: Bayard Clarkson
Consistent genetic abnormalities in human cancers as targets for selective therapies.
The Mount Sinai journal of medicine, New York 1992;59(5):400-4.
1992: S Gulati; L Acaba; Joachim Yahalom; Lilian Reich; Robert J Motzer; John Crown; M Doherty; Bayard Clarkson; Ellin Berman; J Atzpodien
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
Bone marrow transplantation 1992;10(2):129-34.
1992: Ayad Al-Katib; C Y Wang; S McKenzie; Bayard Clarkson; B Koziner
Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
American journal of hematology 1992;40(4):264-9.
1992: Jonathan E Kolitz; Sanford J. Kempin; A Schluger; G Y Wong; Ellin Berman; Suresh C Jhanwar; Z A Arlin; T Gee; Bayard Clarkson
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.
Seminars in oncology 1992;19(3 Suppl 9):27-33.
1992: R M Lemoli; A Tafuri; Annabel Strife; M Andreeff; Bayard Clarkson; S C Gulati
Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors.
Experimental hematology 1992;20(5):569-75.
1992: Coralia I Rivas; David Wisniewski; Annabel Strife; A Perez; C Lambek; S Bruno; Zbigniew Darzynkiewicz; Bayard Clarkson
Constitutive expression of p53 protein in enriched normal human marrow blast cell populations.
Blood 1992;79(8):1982-6.
1992: Ellin Berman; C Little; T Gee; Richard J O'Reilly; Bayard Clarkson
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation.
The New England journal of medicine 1992;326(3):156-60.
1991: Joachim Yahalom; J Ryu; David J Straus; Jeffrey J Gaynor; J Myers; James Caravelli; Bayard Clarkson; Zvi Fuks
Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2193-201.
1991: Ellin Berman; Annabel Strife; David Wisniewski; S Desai; S Gulati; Suresh C Jhanwar; Bayard Clarkson
Duration of the preclinical phase of chronic myelogenous leukemia: a case report.
Blood 1991;78(11):2969-72.
1991: Annabel Strife; C Lambek; A Perez; Zbigniew Darzynkiewicz; J Skierski; S Gulati; J D Haley; Peter ten Dijke; K K Iwata; Bayard Clarkson
The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Cancer research 1991;51(18):4828-36.
1991: Bayard Clarkson
New pharmacologic approaches to treatment of leukemia.
Seminars in hematology 1991;28(3 Suppl 4):99-115.
1991: Ellin Berman; M Weiss; Sanford J. Kempin; T Gee; J Bertino; Bayard Clarkson
Intensive therapy for adult acute lymphoblastic leukemia.
Seminars in hematology 1991;28(3 Suppl 4):72-5.
1991: Bayard Clarkson
Retinoic acid in acute promyelocytic leukemia: the promise and the paradox.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1991;3(6):211-20.
1991: R M Lemoli; S C Gulati; Annabel Strife; C Lambek; A Perez; Bayard Clarkson
Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Leukemia 1991;5(5):386-91.
1991: R M Lemoli; C Gasparetto; David A Scheinberg; Malcolm A S Moore; Bayard Clarkson; S C Gulati
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Blood 1991;77(8):1829-36.
1991: A S Fokas; J B Keller; Bayard Clarkson
Mathematical model of granulocytopoiesis and chronic myelogenous leukemia.
Cancer research 1991;51(8):2084-91.
1991: David J Straus; G Y Wong; J Liu; J Oppenberg; Daniel A Filippa; Jonathan Gold; Kenneth Offit; Bayard Clarkson
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.
The American journal of medicine 1991;90(3):328-37.
1991: David A Scheinberg; D Lovett; Chaitanya R Divgi; MC Graham; Ellin Berman; K Pentlow; N Feirt; Ronald D Finn; Bayard Clarkson; T S Gee
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):478-90.
1991: Ellin Berman; M Adams; R Duigou-Osterndorf; L Godfrey; Bayard Clarkson; M Andreeff
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype.
Blood 1991;77(4):818-25.
1991: S C Gulati; Joachim Yahalom; K Whitmarsh; Bayard Clarkson; T Gee
Factors affecting the outcome of autologous bone marrow transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():51-5.
1991: David Wisniewski; Annabel Strife; Bayard Clarkson
Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction.
Leukemia research 1991;15(9):867-74.
1991: David J Straus; G Wong; Joachim Yahalom; G Varsos; S Gulati; Bayard Clarkson
Diffuse large cell lymphoma. Prognostic factors with treatment.
Leukemia 1991;5 Suppl 1():32-7.
1990: David J Straus; Jeffrey J Gaynor; J Myers; D P Merke; James Caravelli; D Chapman; Joachim Yahalom; Bayard Clarkson
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1173-86.
1990: Ellin Berman; Glenn Heller; Sanford J. Kempin; T Gee; L L Tran; Bayard Clarkson
Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.
Blood 1990;75(4):839-45.
1990: Chihiro Shimazaki; Tohru Inaba; Satoshi Murakami; Naohisa Fujita; Masao Nakagawa; S C Gulati; J Fried; Bayard Clarkson; R Wisniewolski; C Y Wang
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
Progress in clinical and biological research 1990;333():311-9.
1990: F R Schneller; S C Gulati; I B Cunningham; Richard J O'Reilly; Heinz-J. (Joe) Schmitt; Bayard Clarkson
Fusarium infections in patients with hematologic malignancies.
Leukemia research 1990;14(11-12):961-6.
1990: R M Lemoli; S C Gulati; A Perez; Bayard Clarkson
Pharmacological elimination of tumor cells contaminating normal human bone marrow using PTT-119.
Cancer communications 1990;2(2):87-91.
1990: Bayard Clarkson; Jeffrey J Gaynor; C Little; Ellin Berman; Sanford J. Kempin; M Andreeff; S Gulati; I Cunningham; T Gee
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia.
Haematology and blood transfusion 1990;33():397-408.
1990: S Gulati; Jens Atzpodien; R M Lemoli; Chihiro Shimazaki; Bayard Clarkson
Photoradiation methods for purging autologous bone marrow grafts.
Progress in clinical and biological research 1990;333():87-102.
1990: Chihiro Shimazaki; J Fried; A G Perez; David A Scheinberg; Jens Atzpodien; C Y Wang; R Wisniewolski; Bayard Clarkson
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Acta haematologica 1990;83(3):123-9.
1990: A M Schneider; David J Straus; A E Schluger; D A Lowenthal; B Koziner; B J Lee; G Wong; Bayard Clarkson
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):94-102.
1989: S C Gulati; K Whitmarsh; Lilian Reich; Ellin Berman; Joachim Yahalom; J Yopp; Bayard Clarkson; T Gee
Results of autologous bone marrow transplantation for acute leukaemia.
Bone marrow transplantation 1989;4 Suppl 4():61-4.
1989: Kenneth Offit; Suresh C Jhanwar; S A Ebrahim; Daniel A Filippa; Bayard Clarkson; Raju S K Chaganti
t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma.
Blood 1989;74(6):1876-9.
1989: Joachim Yahalom; S Gulati; B Shank; Bayard Clarkson; Zvi Fuks
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
International journal of radiation oncology, biology, physics 1989;17(5):915-22.
1989: Ellin Berman; R Duigou-Osterndorf; Susan E Krown; M P Fanucchi; J Chou; M S Hirsch; Bayard Clarkson; Ting-Chao Chou
Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
Blood 1989;74(4):1281-6.
1989: Kenneth Offit; P R Koduru; R Hollis; Daniel A Filippa; Suresh C Jhanwar; Bayard Clarkson; Raju S K Chaganti
18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance.
British journal of haematology 1989;72(2):178-83.
1989: David A Scheinberg; M Tanimoto; S McKenzie; Annabel Strife; Lloyd J Old; Bayard Clarkson
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
Leukemia 1989;3(6):440-5.
1989: David Wisniewski; Annabel Strife; Z Arlin; R Knowles; C Lambek; S Gulati; B McHendry; S McKenzie; Bayard Clarkson
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Leukemia 1989;3(6):446-52.
1989: M Tanimoto; David A Scheinberg; C Cordon-Cardo; D Huie; Bayard Clarkson; Lloyd J Old
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
Leukemia 1989;3(5):339-48.
1989: I Cunningham; T S Gee; Lilian Reich; Sanford J. Kempin; A N Naval; Bayard Clarkson
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital.
Blood 1989;73(5):1116-22.
1989: Ellin Berman; V Raymond; A Daghestani; Z A Arlin; T S Gee; Sanford J. Kempin; C Hancock; L Williams; Y W Stevens; Bayard Clarkson
4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia.
Cancer research 1989;49(2):477-81.
1989: Ann Jakubowski; L Souza; F Kelly; K Fain; D Budman; Bayard Clarkson; M A Bonilla; Malcolm A S Moore; JL Gabrilove
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
The New England journal of medicine 1989;320(1):38-42.
1989: Kenneth Offit; M E Richardson; Q Q Ceng; A Hampton; P R Koduru; Suresh C Jhanwar; Daniel A Filippa; P H Lieberman; Bayard Clarkson; Raju S K Chaganti
Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma.
Cancer genetics and cytogenetics 1989;37(1):85-93.
1989: Ellin Berman; V Raymond; T S Gee; Sanford J. Kempin; S Gulati; M Andreeff; JL Gabrilove; C W Young; Bayard Clarkson; P H Wiernik
Idarubicin in acute leukemia: results of US trials.
Bone marrow transplantation 1989;4 Suppl 1():49.
1989: S C Gulati; Jeffrey J Gaynor; I Esseesse; T Gee; C Little; M Andreeff; Ellin Berman; Sanford J. Kempin; Bayard Clarkson
Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC).
Bone marrow transplantation 1989;4 Suppl 1():86-9.
1989: S C Gulati; B Shank; Andreas H Sarris; Ellin Berman; T Gee; I Cunningham; N Flomenberg; Richard J O'Reilly; Bayard Clarkson
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
Bone marrow transplantation 1989;4 Suppl 1():116-8.
1989: S C Gulati; C Shimazaki; R M Lemoli; J Atzpodien; Bayard Clarkson
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies.
European journal of haematology. Supplementum 1989;51():164-72.
1989: Jens Atzpodien; C Bührer; S C Gulati; David Wisniewski; S Oz; Holger Kirchner; Thomas Benter; H Poliwoda; Karl Welte; Bayard Clarkson
Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulation.
Haematology and blood transfusion 1989;32():273-80.
1989: S C Gulati; J H Kwon; Jens Atzpodien; Timothy Triche; O M Colvin; Bayard Clarkson
In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation.
Cancer investigation 1989;7(5):411-6.
1989: S C Gulati; J H Kwon; Brian H Kushner; Nai-Kong V Cheung; Jens Atzpodien; K Shum; Bayard Clarkson
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamide.
Cancer investigation 1989;7(5):417-22.
1989: A Körfer; Holger Kirchner; C Schneekloth; C Bührer; David Wisniewski; S Gulati; Bayard Clarkson; R Knowles; H Poliwoda; Jens Atzpodien
Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells.
Acta haematologica 1989;82(4):193-6.
1989: David J Straus; Jeffrey J Gaynor; J Myers; D Merke; D Chapman; James Caravelli; L Z Nisce; B J Lee; Bayard Clarkson
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():191-6.
1988: Chihiro Shimazaki; David Wisniewski; David A Scheinberg; Jens Atzpodien; Annabel Strife; S Gulati; J Fried; R Wisniewolski; C Y Wang; Bayard Clarkson
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Blood 1988;72(4):1248-54.
1988: JL Gabrilove; Ann Jakubowski; K Fain; J Grous; Howard I Scher; C Sternberg; A Yagoda; Bayard Clarkson; M A Bonilla; H F Oettgen
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
The Journal of clinical investigation 1988;82(4):1454-61.
1988: JL Gabrilove; Ann Jakubowski; Howard I Scher; C Sternberg; G Wong; J Grous; A Yagoda; K Fain; Malcolm A S Moore; Bayard Clarkson
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia.
Behring Institute Mitteilungen 1988;(83):229-33.
1988: J E Sokal; G A Gomez; M Baccarani; S Tura; Bayard Clarkson; Francisco Cervantes; Ciril Rozman; F Carbonell; B Anger; Hermann Heimpel
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia.
Blood 1988;72(1):294-8.
1988: JL Gabrilove; Ann Jakubowski; Howard I Scher; C Sternberg; G Wong; J Grous; A Yagoda; K Fain; Malcolm A S Moore; Bayard Clarkson
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.
The New England journal of medicine 1988;318(22):1414-22.
1988: D A Lowenthal; David J Straus; S W Campbell; Jonathan Gold; Bayard Clarkson; B Koziner
AIDS-related lymphoid neoplasia. The Memorial Hospital experience.
Cancer 1988;61(11):2325-37.
1988: Manjeet Chadha; B Shank; Zvi Fuks; Bayard Clarkson; P Bonfiglio; C Gnecco; S Gulati
Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation.
International journal of radiation oncology, biology, physics 1988;14(3):407-15.
1988: Annabel Strife; C Lambek; David Wisniewski; M Wachter; S C Gulati; Bayard Clarkson
Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Cancer research 1988;48(4):1035-41.
1988: Annabel Strife; Bayard Clarkson
Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?
Seminars in hematology 1988;25(1):1-19.
1988: Jens Atzpodien; S C Gulati; J H Kwon; Brian H Kushner; Chihiro Shimazaki; C Bührer; S Oz; Jonathan E Kolitz; Karl Welte; Bayard Clarkson
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo.
Experimental cell biology 1988;56(5):236-44.
1988: Jens Atzpodien; S C Gulati; Chihiro Shimazaki; C Bührer; S Oz; J H Kwon; Jonathan E Kolitz; Bayard Clarkson
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
Oncology 1988;45(6):437-43.
1988: Chihiro Shimazaki; Jens Atzpodien; David Wisniewski; S C Gulati; Jonathan E Kolitz; J Fried; Bayard Clarkson
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.
Acta haematologica 1988;80(4):203-9.
1988: Chihiro Shimazaki; S C Gulati; Jens Atzpodien; J Fried; O M Colvin; Bayard Clarkson
Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213.
Acta haematologica 1988;80(1):17-22.
1988: S C Gulati; Jens Atzpodien; A Langleben; Chihiro Shimazaki; K Jain; J Yopp; R P Ng; O M Colvin; Bayard Clarkson
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
Acta haematologica 1988;80(2):65-70.
1987: David Wisniewski; Annabel Strife; J Atzpodien; Bayard Clarkson
Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Cancer research 1987;47(18):4788-94.
1987: M E Richardson; Q G Chen; Daniel A Filippa; Kenneth Offit; A Hampton; P R Koduru; Suresh C Jhanwar; P H Lieberman; Bayard Clarkson; Raju S K Chaganti
Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes.
Blood 1987;70(2):444-7.
1987: J Atzpodien; S C Gulati; A Strife; Bayard Clarkson
Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts.
Blood 1987;70(2):484-9.
1987: Annabel Strife; C Lambek; David Wisniewski; S Gulati; J C Gasson; D W Golde; K Welte; J L Gabrilove; Bayard Clarkson
Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells.
Blood 1987;69(5):1508-23.
1987: Z A Arlin; D Liebowitz; Bayard Clarkson
Pseudo-Philadelphia-positive acute lymphoblastic leukemia (Ph1 + ALL)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):512.
1987: David J Straus; Jeffrey J Gaynor; P H Leiberman; D A Filippa; B Koziner; Bayard Clarkson
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
The American journal of medicine 1987;82(2):247-56.
1987: J R Redman; Daiva Regina Bajorunas; M C Goldstein; D P Evenson; R J Gralla; M J Lacher; B Koziner; B J Lee; David J Straus; Bayard Clarkson
Semen cryopreservation and artificial insemination for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(2):233-8.
1987: David Wisniewski; R Knowles; M Wachter; Annabel Strife; Bayard Clarkson
Expression of two natural killer cell antigens, H-25 and H-366, by human immature myeloid cells and by erythroid and granulocytic/monocytic colony-forming units.
Blood 1987;69(2):419-29.
1987: P R Koduru; Daniel A Filippa; M E Richardson; Suresh C Jhanwar; Seeta Chaganti; B Koziner; Bayard Clarkson; P H Lieberman; Raju S K Chaganti
Cytogenetic and histologic correlations in malignant lymphoma.
Blood 1987;69(1):97-102.
1987: M Andreeff; Jeffrey J Gaynor; D Chapman; C Little; T Gee; Bayard Clarkson
Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experience.
Haematology and blood transfusion 1987;30():111-24.
1987: T T Chang; S Gulati; T C Chou; M Colvin; Bayard Clarkson
Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors.
Cancer research 1987;47(1):119-22.
1987: Jens Atzpodien; S C Gulati; J H Kwon; M Wachter; J Fried; Bayard Clarkson
Human bone marrow CFU-GM and BFU-E localized by light scatter cell sorting.
Experimental cell biology 1987;55(5):265-70.
1987: Jens Atzpodien; David Wisniewski; S Gulati; K Welte; R Knowles; Bayard Clarkson
Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Natural immunity and cell growth regulation 1987;6(3):129-40.
1987: J Fried; A G Perez; Chihiro Shimazaki; Bayard Clarkson
Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies.
Experimental cell biology 1987;55(6):322-30.
1986: J Atzpodien; S C Gulati; Bayard Clarkson
Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
Cancer research 1986;46(10):4892-5.
1986: L Danieu; G Wong; B Koziner; Bayard Clarkson
Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
Cancer research 1986;46(10):5372-9.
1986: P H Lieberman; D A Filippa; David J Straus; Howard T Thaler; C Cirrincione; Bayard Clarkson
Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years.
The American journal of medicine 1986;81(3):365-80.
1986: Z A Arlin; Suresh C Jhanwar; Bayard Clarkson
Philadelphia chromosome mosaicism in chronic granulocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(7):1149-50.
1986: J B Konopka; Steven S Clark; J McLaughlin; M Nitta; Y Kato; A Strife; Bayard Clarkson; O N Witte
Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(11):4049-52.
1986: M Nishikori; H Hansen; Bayard Clarkson
Inhibition of recovery by actinomycin D from bleomycin-induced potentially lethal damage in a B-lymphoma cell line.
Nihon Gan Chiryo Gakkai shi 1986;21(4):736-43.
1986: Pasquale Benedetto; R Mertelsmann; T H Szatrowski; M Andreeff; T Gee; Z Arlin; Sanford J. Kempin; Bayard Clarkson
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(4):489-95.
1986: Anwar N Mohamed; Bayard Clarkson; Raju S K Chaganti
High resolution banding of chronic myeloid leukemia chromosomes.
Cancer genetics and cytogenetics 1986;20(3-4):209-22.
1986: B J Kennedy; P Calabresi; Bayard Clarkson; E Frenkel
Training programs in medical oncology.
Annals of internal medicine 1986;104(2):279.
1986: B J Kennedy; P Calabresi; Bayard Clarkson; E Frenkel
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(2):269-70.
1986: S C Gulati; Roger Vega; T Gee; B Koziner; Bayard Clarkson
Growth and development of children born to patients after cancer therapy.
Cancer investigation 1986;4(3):197-205.
1986: Bayard Clarkson; T Gee; Z A Arlin; R Mertelsmann; Sanford J. Kempin; R E Dinsmore; Richard J O'Reilly; M Andreeff; Ellin Berman; C Little
Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature.
Critical reviews in oncology/hematology 1986;4(3):221-48.
1986: B Koziner; J Stavnezer; Ayad Al-Katib; D Gebhard; A Mittelman; M Andreeff; Bayard Clarkson
Surface immunoglobulin light chain expression in pre-B cell leukemias.
Annals of the New York Academy of Sciences 1986;468():211-26.
1985: B J Kennedy; P Calabresi; Bayard Clarkson; E Frenkel
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology.
Seminars in oncology 1985;12(4):xxv-xxvi.
1985: M J Magee; S McKenzie; D A Filippa; Z A Arlin; T S Gee; Bayard Clarkson
Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients.
Cancer 1985;56(11):2557-62.
1985: M Nitta; Y Kato; Annabel Strife; M Wachter; J Fried; A Perez; Suresh C Jhanwar; R Duigou-Osterndorf; Raju S K Chaganti; Bayard Clarkson
Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia.
Blood 1985;66(5):1053-61.
1985: I Svet-Moldavsky; S C Gulati; Bayard Clarkson
Growth of human bone marrow in vitro.
Cell biology international reports 1985;9(9):833-40.
1985: T T Chang; S C Gulati; T C Chou; Roger Vega; L Gandola; S M Ibrahim; J Yopp; M Colvin; Bayard Clarkson
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
Cancer research 1985;45(6):2434-9.
1985: Bayard Clarkson; S Ellis; C Little; T Gee; Z Arlin; R Mertelsmann; M Andreeff; Sanford J. Kempin; B Koziner; Raju S K Chaganti
Acute lymphoblastic leukemia in adults.
Seminars in oncology 1985;12(2):160-79.
1985: Z A Arlin; R Mertelsmann; Ellin Berman; T Gee; E Kurland; Raju S K Chaganti; Suresh C Jhanwar; Malcolm A S Moore; Bayard Clarkson
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(4):473-6.
1985: S Siena; Hugo Castro-Malaspina; S C Gulati; L Lu; M O Colvin; Bayard Clarkson; Richard J O'Reilly; Malcolm A S Moore
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow.
Blood 1985;65(3):655-62.
1985: David Wisniewski; Annabel Strife; M Wachter; Bayard Clarkson
Regulation of human peripheral blood erythroid burst-forming unit growth by T lymphocytes and T lymphocyte subpopulations defined by OKT4 and OKT8 monoclonal antibodies.
Blood 1985;65(2):456-63.
1985: Bayard Clarkson
Chronic myelogenous leukemia: is aggressive treatment indicated?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(2):135-9.
1985: Bayard Clarkson; Jeffrey J Gaynor; B R Franza; M Furth
Recent advances in the treatment of acute lymphoblastic leukemia in adults and future prospects.
Transactions of the American Clinical and Climatological Association 1985;96():41-55.
1985: Mark G Kris; R Mertelsmann; Suresh C Jhanwar; Raju S K Chaganti; T H Szatrowski; T S Gee; Z Arlin; Sanford J. Kempin; Pasquale Benedetto; Bayard Clarkson
Relationship of Auer rods and chromosome findings to outcome in eighty-nine adults with acute nonlymphoblastic leukemia.
Leukemia research 1985;9(10):1231-5.
1985: Bayard Clarkson
Summary overview of clinical session.
Haematology and blood transfusion 1985;29():96-101.
1984: S A Henry; Donald Armstrong; Sanford J. Kempin; T Gee; Z Arlin; Bayard Clarkson
Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
The American journal of medicine 1984;77(4):663-6.
1984: R Mertelsmann; K Welte; C Sternberg; Richard J O'Reilly; Malcolm A S Moore; Bayard Clarkson; H F Oettgen
Treatment of immunodeficiency with interleukin-2: initial exploration.
Journal of biological response modifiers 1984;3(5):483-90.
1984: J R Redman; D Vugrin; Z A Arlin; T S Gee; Sanford J. Kempin; J H Godbold; D Schottenfeld; Bayard Clarkson
Leukemia following treatment of germ cell tumors in men.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(10):1080-7.
1984: Ayad Al-Katib; B Koziner; E Kurland; C Little; D Labriola; Howard T Thaler; David J Straus; B Lee; Bayard Clarkson
Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables.
Cancer 1984;53(11):2404-12.
1984: M S Blumenreich; T M Woodcock; M Andreeff; W Hiddemann; T C Chou; K Vale; M O'Hehir; Bayard Clarkson; C W Young
Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.
Cancer research 1984;44(5):2203-7.
1984: M Nishikori; H Hansen; Suresh C Jhanwar; J Fried; P Sordillo; B Koziner; K Lloyd; Bayard Clarkson
Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation.
Cancer genetics and cytogenetics 1984;12(1):39-50.
1984: J E Sokal; E B Cox; M Baccarani; S Tura; G A Gomez; Joseph Robertson; C Y Tso; T J Braun; Bayard Clarkson; Francisco Cervantes
Prognostic discrimination in "good-risk" chronic granulocytic leukemia.
Blood 1984;63(4):789-99.
1984: M S Blumenreich; T C Chou; M Andreeff; K Vale; Bayard Clarkson; C W Young
Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
Cancer research 1984;44(2):825-30.
1984: Z Arlin; Sanford J. Kempin; R Mertelsmann; T Gee; C Higgins; Suresh C Jhanwar; Raju S K Chaganti; Bayard Clarkson
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy.
Blood 1984;63(1):211-2.
1983: K Jain; S Gulati; Bayard Clarkson
Modern cancer chemotherapy.
Indian journal of pediatrics 1983;50(407):651-9.
1983: J Fried; A G Perez; J M Doblin; Bayard Clarkson
Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
Cell and tissue kinetics 1983;16(6):539-48.
1983: E J Gold; R H Mertelsmann; L M Itri; T Gee; Z Arlin; Sanford J. Kempin; Bayard Clarkson; Malcolm A S Moore
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.
Cancer treatment reports 1983;67(11):981-6.
1983: S C Gulati; C Gulati; Roger Vega; L Gandola; J Yopp; R Dinsmore; Richard J O'Reilly; Bayard Clarkson
Non-Hodgkin's lymphoma.
Indian journal of pediatrics 1983;50(407):667-74.
1983: S C Gulati; Roger Vega; L Gandola; C Gulati; J Yopp; Richard J O'Reilly; Bayard Clarkson
Neuroblastoma.
Indian journal of pediatrics 1983;50(407):661-5.
1983: K Jain; Z Arlin; R Mertelsmann; T Gee; Sanford J. Kempin; B Koziner; A Middleton; Suresh C Jhanwar; Raju S K Chaganti; Bayard Clarkson
Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(11):669-76.
1983: Patrick J Stiff; A J Murgo; R E Wittes; M F DeRisi; Bayard Clarkson
Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytaphereses replace bone marrow for autologous transplantation?
Transfusion 1983;23(6):500-3.
1983: E J Gold; M Conjalka; L M Pelus; Suresh C Jhanwar; H Broxmeyer; A B Middleton; Bayard Clarkson; Malcolm A S Moore
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(10):627-34.
1983: M S Blumenreich; A Strife; Bayard Clarkson
A technique to quantify cytoreduction in the bone marrow induced by cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(9):552-8.
1983: Raju S K Chaganti; Suresh C Jhanwar; Z Arlin; B Koziner; A Ambati; M Andreeff; Bayard Clarkson
Non-T, non-B acute lymphoblastic leukemia (L3) with t(8;22) and two 14q+ chromosomes.
Cancer genetics and cytogenetics 1983;10(1):95-103.
1983: Z A Arlin; Sanford J. Kempin; R Mertelsmann; T S Gee; Bayard Clarkson
Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(8):513.
1983: Annabel Strife; C Lambek; David Wisniewski; Z Arlin; Howard T Thaler; Bayard Clarkson
Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients.
Blood 1983;62(2):389-97.
1983: W Hiddemann; T Büchner; M Andreeff; Z Arlin; B Wörmann; Bayard Clarkson
[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity].
Onkologie 1983;6(4):179-83.
1983: I A Svet-Moldavskaya; S N Zinzar; G J Svet-Moldavsky; Z Arlin; C Vergara; B Koziner; Bayard Clarkson; J F Holland
Phenomenon of formation of giant fat-containing cells in human bone marrow cultures induced by human serum factor: normal and leukemic patterns.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(15):4847-50.
1983: C D Platsoucas; H J Hansen; J R Redman; S Berenson; B J Lee; Bayard Clarkson
T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.
Journal of clinical immunology 1983;3(3):277-84.
1983: E J Gold; R H Mertelsmann; D A Filippa; T H Szatrowski; B Koziner; Bayard Clarkson
Prognostic significance of receptors for the third component of complement an heavy chain phenotype in diffuse B-cell lymphomas.
Blood 1983;62(1):107-11.
1983: Raju S K Chaganti; Suresh C Jhanwar; B Koziner; Z Arlin; R Mertelsmann; Bayard Clarkson
Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome.
Blood 1983;61(6):1265-8.
1983: Z Arlin; R Mertelsmann; Sanford J. Kempin; T Gee; Bayard Clarkson
Is further intensification of treatment warranted in acute nonlymphoblastic leukemia?
Cancer treatment reports 1983;67(2):202-4.
1983: Patrick J Stiff; A J Murgo; C G Zaroulis; M F DeRisi; Bayard Clarkson
Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch.
Cryobiology 1983;20(1):17-24.
1983: Z A Arlin; Bayard Clarkson
The treatment of acute nonlymphoblastic leukemia in adults.
Advances in internal medicine 1983;28():303-23.
1983: David J Straus; J Myers; B Koziner; B J Lee; Bayard Clarkson
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Cancer chemotherapy and pharmacology 1983;11(2):80-5.
1983: Patrick J Stiff; M F DeRisi; A Langleben; S Gulati; A Koester; V Lanzotti; Bayard Clarkson
Autologous bone marrow transplantation using unfractionated cells without rate-controlled freezing in hydroxyethyl starch and dimethyl sulfoxide.
Annals of the New York Academy of Sciences 1983;411():378-80.
1983: David J Straus; D A Filippa; P H Lieberman; B Koziner; Howard T Thaler; Bayard Clarkson
The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969.
Cancer 1983;51(1):101-9.
1982: David Wisniewski; C Platsoucas; Annabel Strife; C Lambek; Bayard Clarkson
Enrichment of hematopoietic progenitor cells (CFUC and BFUE) from human peripheral blood.
Experimental hematology 1982;10(10):817-29.
1982: Z A Arlin; M P Fanucchi; T S Gee; Sanford J. Kempin; R Mertelsmann; C W Young; Bayard Clarkson
Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).
Blood 1982;60(5):1224-6.
1982: Sanford J. Kempin; B J Lee; Howard T Thaler; B Koziner; S Hecht; T Gee; Z Arlin; C Little; David J Straus; Lilian Reich; E Phillips; H Al-Mondhiry; M Dowling; K Mayer; Bayard Clarkson
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
Blood 1982;60(5):1110-21.
1982: C D Platsoucas; M Galinski; Sanford J. Kempin; Lilian Reich; Bayard Clarkson; R A Good
Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(5):2305-12.
1982: S Passe; V Miké; R Mertelsmann; T S Gee; Bayard Clarkson
Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.
Cancer 1982;50(8):1462-71.
1982: B Koziner; D Gebhard; T Denny; S McKenzie; Bayard Clarkson; D A Miller; R L Evans
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies.
Blood 1982;60(3):752-7.
1982: W Hiddemann; T Büchner; M Andreeff; B Wörmann; M R Melamed; Bayard Clarkson
Cell kinetics in acute leukemia: a critical reevaluation based on new data.
Cancer 1982;50(2):250-8.
1982: J Fried; J Doblin; S Takamoto; A Perez; H Hansen; Bayard Clarkson
Effects of Hoechst 33342 on survival and growth of two tumor cell lines and on hematopoietically normal bone marrow cells.
Cytometry 1982;3(1):42-7.
1982: B Koziner; C Little; S Passe; Howard T Thaler; R Sklaroff; David J Straus; B J Lee; Bayard Clarkson
Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables.
Cancer 1982;49(8):1571-9.
1982: C W Young; David J Straus; J Myers; S Passe; L Z Nisce; B J Lee; B Koziner; Z Arlin; Sanford J. Kempin; T Gee; Bayard Clarkson
Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.
Cancer treatment reports 1982;66(4):907-14.
1982: T Goto; M Nishikori; Z Arlin; T Gee; Sanford J. Kempin; J Burchenal; Annabel Strife; David Wisniewski; C Lambek; C Little; Suresh C Jhanwar; Raju S K Chaganti; Bayard Clarkson
Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.
Blood 1982;59(4):793-808.
1982: Raju S K Chaganti; Suresh C Jhanwar; Z A Arlin; Bayard Clarkson
Chronic myelogenous leukemia in an XYY male.
Cancer genetics and cytogenetics 1982;5(3):223-6.
1982: Raju S K Chaganti; R B Bailey; Suresh C Jhanwar; Z A Arlin; Bayard Clarkson
Chronic myelogenous leukemia in the monosomic cell line of a fertile Turner syndrome mosaic (45,X/46,XX).
Cancer genetics and cytogenetics 1982;5(3):215-21.
1982: W Hiddemann; Bayard Clarkson; T Büchner; M R Melamed; M Andreeff
Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia.
Blood 1982;59(2):216-25.
1982: J Fried; A G Perez; J Doblin; Bayard Clarkson
Effects of cytosine arabinoside and daunorubicin on survival and cell cycle progression of Chinese hamster ovary cells.
Cell and tissue kinetics 1982;15(1):11-23.
1982: Jack Kutti; C G Zaroulis; R E Dinsmore; L Reich; Bayard Clarkson; R A Good
A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.
Transfusion 1982;22(1):44-7.
1982: R Mertelsmann; Malcolm A S Moore; Bayard Clarkson
Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia.
Blood cells 1982;8(3):561-83.
1982: W Hiddemann; T Büchner; M Andreeff; B Wörmann; M R Melamed; Bayard Clarkson
Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis. Comparison of bone marrow biopsy and aspiration material.
Leukemia research 1982;6(4):601-12.
1981: P K Schauer; David J Straus; C M Bagley; R H Rudolph; J D McCracken; J Huff; H Glucksburg; D E Bauermeister; Bayard Clarkson
Angioimmunoblastic lymphadenopathy: clinical spectrum of disease.
Cancer 1981;48(11):2493-8.
1981: Bayard Clarkson
The elusive goal: presidential address.
Cancer research 1981;41(12 Pt 1):4865-84.
1981: Bayard Clarkson
Results of intensive treatment of chronic myelogenous leukemia.
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society 1981;44(7):1263-76.
1981: R Mertelsmann; Ronny Drapkin; T S Gee; Sanford J. Kempin; S Passe; Howard T Thaler; Z Arlin; M Dowling; P Dufour; S McKenzie; L To; E Comacho; H F Oettgen; J H Burchenal; Bayard Clarkson
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
Cancer 1981;48(10):2136-42.
1981: I A Svet-Moldavskaya; Z Arlin; G J Svet-Moldavsky; Bayard Clarkson; B Koziner; N Mendelsohn; S N Zinzar; J F Holland
Induction by tumor-promoting phorbol diester of colony-stimulating activity in human myeloid leukemia cells transformed to macrophage-mimicking cells.
Cancer research 1981;41(11 Pt 1):4335-40.
1981: R Mertelsmann; Malcolm A S Moore; H E Broxmeyer; C Cirrincione; Bayard Clarkson
Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia.
Cancer research 1981;41(11 Pt 2):4844-8.
1981: I A Svet-Moldavskaya; G J Svet-Moldavsky; S N Zinzar; J F Holland; C Vergara; Z Arlin; B Koziner; Bayard Clarkson
Induction of giant fat cells in human bone marrow culture by human serum factor.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1981;35(5):141-2.
1981: I Svet-Moldavsky; G Svet-Moldavsky; S Zinzar; J Holland; C Vergara; Z Arlin; B Koziner; Bayard Clarkson
The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1981;35(5):142-4.
1981: David J Straus; B J Lee; B Koziner; L Z Nisce; C W Young; Bayard Clarkson
The treatment of advanced hodgkin's disease.
Blut 1981;43(2):119-24.
1981: J Fried; A G Perez; J M Doblin; Bayard Clarkson
Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
Cancer research 1981;41(7):2627-32.
1981: H Hansen; B Koziner; Bayard Clarkson
Marker and kinetic studies in the non-Hodgkin's lymphomas.
The American journal of medicine 1981;71(1):107-23.
1981: J W Singer; J W Adamson; Z A Arlin; Sanford J. Kempin; Bayard Clarkson; P J Fialkow
Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy.
The Journal of clinical investigation 1981;67(6):1593-8.
1981: A Yen; C Lambek; Bayard Clarkson
Inaccuracy of estimations of s phase fraction by reduction in cloning efficiency with hydroxyurea or tritiated thymidine.
Cell and tissue kinetics 1981;14(3):301-8.
1981: A Friedman; P Schauer; R Mertelsmann; C Cirrincione; Howard T Thaler; P Dufour; S B Ellis; H Teitelbaum; Sanford J. Kempin; T S Gee; Z Arlin; Bayard Clarkson
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission.
Blood 1981;57(4):798-801.
1981: J Fried; A G Perez; J M Doblin; Bayard Clarkson
Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture.
Cancer research 1981;41(3):1127-32.
1981: David J Straus; S Passe; B Koziner; B J Lee; C W Young; Bayard Clarkson
Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literature.
Cancer treatment reports 1981;65(3-4):207-11.
1981: W Hiddemann; M Andreeff; Bayard Clarkson
Quantitation of chemotherapy-induced cytoreduction in acute leukemia.
Haematology and blood transfusion 1981;26():73-6.
1981: M Nishikori; H Hansen; A Yen; Bayard Clarkson
Cloning of fresh lymphoma cells.
Medical and pediatric oncology 1981;9(2):167-73.
1981: J Fried; A G Perez; J Doblin; Bayard Clarkson
Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.
Cancer treatment reports 1981;65(1-2):153-6.
1981: R Mertelsmann; Malcolm A S Moore; Bayard Clarkson
Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells.
Haematology and blood transfusion 1981;26():68-72.
1981: Z A Arlin; N Flomenberg; T S Gee; Sanford J. Kempin; C Dellaquila; R Mertelsmann; David J Straus; C W Young; Bayard Clarkson
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.
Cancer clinical trials 1981;4(3):317-21.
1980: David J Straus; R Mertelsmann; B Koziner; S McKenzie; E de Harven; Z A Arlin; Sanford J. Kempin; H Broxmeyer; Malcolm A S Moore; C J Menendez-Botet; T S Gee; Bayard Clarkson
The acute monocytic leukemias: multidisciplinary studies in 45 patients.
Medicine 1980;59(6):409-25.
1980: B Koziner; Sanford J. Kempin; S Passe; T Gee; R A Good; Bayard Clarkson
Characterization of B-cell leukemias: a tentative immunomorphological scheme.
Blood 1980;56(5):815-23.
1980: R Mertelsmann; H Tzvi Thaler; L To; T S Gee; S McKenzie; P Schauer; A Friedman; Z Arlin; C Cirrincione; Bayard Clarkson
Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia.
Blood 1980;56(5):773-81.
1980: Z A Arlin; R B Sklaroff; T S Gee; Sanford J. Kempin; J Howard; Bayard Clarkson; C W Young
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
Cancer research 1980;40(9):3304-6.
1980: J W Singer; Z A Arlin; V Najfeld; J W Adamson; Sanford J. Kempin; Bayard Clarkson; P J Fialkow
Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome.
Blood 1980;56(3):356-60.
1980: C D Platsoucas; Gabriel Fernandes; S L Gupta; Sanford J. Kempin; Bayard Clarkson; R A Good; S Gupta
Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(3):1216-23.
1980: S C Gulati; R Mertelsmann; T Gee; R A Good; Bayard Clarkson; Malcolm A S Moore; B Koziner
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease.
Cancer 1980;46(4):725-9.
1980: R S Schulof; B J Lee; M J Lacher; David J Straus; Bayard Clarkson; R A Good; S Gupta
Concanavalin A-induced suppressor cell activity in Hodgkin's disease.
Clinical immunology and immunopathology 1980;16(4):454-62.
1980: M Haghbin; M L Murphy; C C Tan; Bayard Clarkson; Howard T Thaler; S Passe; J Burchenal
A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens.
Cancer 1980;46(2):241-52.
1980: David J Straus; J Myers; S Passe; C W Young; L Z Nisce; B J Lee; B Koziner; Z Arlin; Sanford J. Kempin; T Gee; Bayard Clarkson
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Cancer 1980;46(2):233-40.
1980: M Andreeff; Bayard Clarkson
[Pro and con: Aggressive or conventional treatment of chronic myelogenous leukemia. Arguments in favor of aggressive treatment].
Der Internist 1980;21(7):371-5.
1980: L M Pelus; H E Broxmeyer; Bayard Clarkson; Malcolm A S Moore
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Cancer research 1980;40(7):2512-5.
1980: J D Beck; M Haghbin; N Wollner; R Mertelsmann; T Garrett; B Koziner; Bayard Clarkson; D Miller; R A Good; S Gupta
Subpopulations of human T lymphocytes. VI. Analysis of cell markers in acute lymphoblastic leukemia with special reference to Fc receptor expression on E-rosette-forming blasts.
Cancer 1980;46(1):45-9.
1980: J D Beck; B Koziner; R Mertelsmann; C D Platsoucas; Bayard Clarkson; R A Good
B cells from a patient with chronic lymphocytic leukemia bind to sheep erythrocytes: an immunological analysis.
Clinical immunology and immunopathology 1980;16(2):233-7.
1980: S C Gulati; P Sordillo; Sanford J. Kempin; Lilian Reich; G B Magill; E Scheiner; Bayard Clarkson
Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil.
Cancer 1980;45(9):2252-7.
1980: R E Dinsmore; David J Straus; M S Pollack; J M Woodruff; T J Garrett; C W Young; Bayard Clarkson; Bo Dupont
Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.
Blood 1980;55(5):831-4.
1980: A J Murgo; J Fried; D Burchenal; K L Vale; Annabel Strife; T Woodcock; C W Young; Bayard Clarkson
Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line.
Cancer research 1980;40(5):1543-9.
1980: C D Platsoucas; Sanford J. Kempin; A Karanas; Bayard Clarkson; R A Good; S Gupta
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia.
Clinical and experimental immunology 1980;40(2):256-63.
1980: E A Phillips; Sanford J. Kempin; Lilian Reich; Bayard Clarkson
Bleomycin for treatment of immune cytopenia.
The New England journal of medicine 1980;302(18):1031.
1980: T J Garrett; E Grossbard; S Hopfan; B Koziner; Bayard Clarkson; R A Good; Richard J O'Reilly
Bone marrow transplantation for the therapy of refractory adult T cell acute lymphoblastic leukemia.
Cancer 1980;45(8):2006-8.
1980: B Koziner; R Mertelsmann; M Andreeff; Z Arlin; H Hansen; E De Harven; S McKenzie; T Gee; R A Good; Bayard Clarkson
Heterogeneity of cell lineages in L3 leukemias.
Blood 1980;55(4):694-8.
1980: J Fried; A G Perez; Bayard Clarkson
Quantitative analysis of cell cycle progression of synchronous cells by flow cytometry.
Experimental cell research 1980;126(1):63-74.
1980: M Andreeff; Z Darzynkiewicz; T K Sharpless; Bayard Clarkson; M R Melamed
Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA.
Blood 1980;55(2):282-93.
1980: David J Straus; C W Young; B J Lee; B Koziner; Bayard Clarkson; L Z Nisce
The treatment of advanced Hodgkin's disease at Memorial Hospital.
Clinical bulletin 1980;10(4):138-43.
1980: M J Modak; R Mertelsmann; B Koziner; Rajendra Pahwa; Malcolm A S Moore; Bayard Clarkson; R A Good
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.
Journal of cancer research and clinical oncology 1980;98(1):91-104.
1980: Jack Kutti; C G Zaroulis; J Kulpa; L Reich; Bayard Clarkson; R A Good
Plasma beta-thromboglobulin values in thrombocytopenic patients with acute leukemia.
American journal of hematology 1980;8(4):339-45.
1979: I A Svet-Moldavskaya; S N Zinzar; G J Svet-Moldavsky; P E Mann; J G Bekesi; J F Holland; Bayard Clarkson; Z Arlin; B Koziner
Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1979;31(9-10):252-7.
1979: David J Straus; M Andreeff; H J Hansen; R Mertelsmann; B Koziner; Raju S K Chaganti; T S Gee; S McKenzie; M R Melamed; Bayard Clarkson
The coexistence of acute myeloblastic leukemia and diffuse histiocytic lymphoma in the same patient as demonstrated by multiparameter analysis.
Blood 1979;54(6):1428-33.
1979: I Cunningham; T Gee; M Dowling; Raju S K Chaganti; R Bailey; S Hopfan; L Bowden; A Turnbull; W Knapper; Bayard Clarkson
Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).
Blood 1979;53(3):375-95.
1979: B Koziner; Sanford J. Kempin; T Gee; B J Lee; R A Good; Bayard Clarkson
Cell-marker analysis of complete remissions in chronic B-cell leukaemias.
Lancet 1979;1(8108):158.
1979: R Mertelsmann; B Koziner; D A Filippa; E Grossbard; G Incefy; Malcolm A S Moore; Bayard Clarkson
Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias.
Haematology and blood transfusion 1979;23():131-8.
1979: R Mertelsmann; D A Filippa; B Koziner; E Grossbard; J Beck; Malcolm A S Moore; P H Lieberman; Bayard Clarkson; S Gupta; R A Good
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas.
Advances in experimental medicine and biology 1979;114():553-60.
1979: G Ia Svet-Moldavskiĭ; J F Khollend; I A Svet-Moldavskiĭ; Bayard Clarkson
[Differentiation of human normal and leukemic bone marrow and blood cells in tissue culture upon exposure to a tumor promotor].
Doklady Akademii nauk SSSR 1979;249(3):720-2.
1979: R L Drapkin; M Adreeff; B Koziner; A Strife; D Wisniewski; Z Darzynkiewicz; M R Melamed; Bayard Clarkson
Subpopulations of human peripheral blood cells: analysis of granulocytic progenitor cells by flow cytometry and immunologic surface markers.
American journal of hematology 1979;7(2):163-72.
1978: J Fried; A G Perez; Bayard Clarkson
Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1978;26(11):921-33.
1978: T S Gee; I Cunningham; M D Dowling; R Chaghanti; Bayard Clarkson
The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia.
Bollettino dell'Istituto sieroterapico milanese 1978;57(3):289-93.
1978: Z A Arlin; J Fried; Bayard Clarkson
Therapeutic role of cell kinetics in acute leukaemia.
Clinics in haematology 1978;7(2):339-62.
1978: R L Drapkin; T S Gee; M D Dowling; Z Arlin; S McKenzie; Sanford J. Kempin; Bayard Clarkson
Prophylactic heparin therapy in acute promyelocytic leukemia.
Cancer 1978;41(6):2484-90.
1978: R Mertelsmann; B Koziner; R Ralph; D Filippa; S McKenzie; Z A Arlin; T S Gee; Malcolm A S Moore; Bayard Clarkson
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia.
Blood 1978;51(6):1051-6.
1978: Bayard Clarkson
Current concepts of leukemia and results of recent treatment programs.
Transplantation proceedings 1978;10(1):157-62.
1977: D C Case; D J Lee; Bayard Clarkson
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
The American journal of medicine 1977;63(6):897-903.
1977: Bayard Clarkson; J Fried; T C Chou; A Strife; R Ferguson; S Sullivan; T Kitahara; A Oyama
Duration of the dormant state in an established cell line of human hematopoietic cells.
Cancer research 1977;37(12):4506-22.
1977: T C Chou; Z Arlin; Bayard Clarkson; F S Phillips
Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
Cancer research 1977;37(10):3561-70.
1977: B Koziner; D A Filippa; R Mertelsmann; S Gupta; Bayard Clarkson; R A Good; F P Siegal
Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology.
The American journal of medicine 1977;63(4):556-67.
1977: T J Garrett; T Takahashi; Bayard Clarkson; Lloyd J Old
Detection of antibody to autologous human leukemia cells by immune adherence assays.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(10):4587-90.
1977: A Yen; J Fried; Bayard Clarkson
Alternative modes of population growth inhibition in a human lymphoid cell line growing in suspension.
Experimental cell research 1977;107(2):325-41.
1977: B Koziner; S McKenzie; David J Straus; Bayard Clarkson; R A Good; F P Siegal
Cell marker analysis in acute monocytic leukemias.
Blood 1977;49(6):895-901.
1977: C Nicolini; F Kendall; R Baserga; C Dessaive; Bayard Clarkson; J Fried
The G0-G1 transition of WI38 cells. I. Laser flow microfluorimetric studies.
Experimental cell research 1977;106(1):111-8.
1977: Z A Arlin; J W Chiao; J Fried; M D Dowling; Bayard Clarkson; R A Good
Relationship of a T-lymphocyte marker to phase of cell cycle and morphology of leukemic cells.
Cancer 1977;39(3):1101-4.
1977: E A Phillips; Sanford J. Kempin; S Passe; V Miké; Bayard Clarkson
Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy.
Clinics in haematology 1977;6(1):203-22.
1977: T J Garrett; T S Gee; M D Dowling; B J Lee; M P Middleman; Bayard Clarkson; C W Young
Cyclophosphamide L2 protocol: a combination chemotherapeutic regimen for advanced non-hodgkin's lymphoma.
Cancer treatment reports 1977;61(1):7-16.
1976: T J Garrett; T S Gee; P H Lieberman; S McKenzie; Bayard Clarkson
The role of bone marrow aspiration and biopsy in detecting marrow involvement by nonhematologic malignancies.
Cancer 1976;38(6):2401-3.
1976: J Fried; Z Arlin; A Alikpala; C T Tan; Bayard Clarkson
Kinetic response of human leukemic and lymphoma cells in vivo to combination chemotherapy using flow microfluorometry.
Cancer treatment reports 1976;60(12):1937-46.
1976: C Nicolini; F Kendall; C Desaive; R Baserga; Bayard Clarkson; J Fried
Physical-chemical characterization of living cells by laser-flow microfluorometry.
Cancer treatment reports 1976;60(12):1819-27.
1976: J Fried; A G Perez; Bayard Clarkson
Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data.
The Journal of cell biology 1976;71(1):172-81.
1976: D C Case; C W Young; L Nisce; B J Lee; Bayard Clarkson
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
Cancer treatment reports 1976;60(9):1217-23.
1976: J Fried; X Yataganas; T Kitahara; A Perez; R Ferguson; S Sullivan; Bayard Clarkson
Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations.
Computers and biomedical research, an international journal 1976;9(3):277-90.
1976: T S Gee; M Haghbin; M D Dowling; I Cunningham; M P Middleman; Bayard Clarkson
Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.
Cancer 1976;37(3):1256-64.
1976: X Yataganas; A Strife; A Perez; Bayard Clarkson
Cell kill kinetics with hydroxyurea.
Medical and pediatric oncology 1976;2(1):39-54.
1975: A Polliack; F P Siegal; Bayard Clarkson; S M Fu; R J Winchester; N Lampen; M Siegal; E De Harven
A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders.
Scandinavian journal of haematology 1975;15(5):359-76.
1975: A Yen; J Fried; T Kitahara; A Strife; Bayard Clarkson
The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase.
Experimental cell research 1975;95(2):303-10.
1975: A Yen; J Fried; T Kitahara; A Stride; Bayard Clarkson
The kinetic significance of cell size, I. Variation of cell cycle parameters with size measured at mitosis.
Experimental cell research 1975;95(2):295-302.
1975: A Polliack; S McKenzie; T Gee; N Lampen; E de Harven; Bayard Clarkson
A scanning electron microscopic study of 34 cases of acute granulocytic, myelomonocytic, monoblastic and histiocytic leukemia.
The American journal of medicine 1975;59(3):308-15.
1975: Bayard Clarkson; M D Dowling; T S Gee; I B Cunningham; J H Burchenal
Treatment of acute leukemia in adults.
Cancer 1975;36(2):775-95.
1975: P F Sheehy; J Fried; M D Dowling; Bayard Clarkson
Studies of cellular proliferation in human leukemia. VIII. The generation time and growth fraction in lymphosarcoma in a leukemic phase during advanced and early relapsing disease.
Cancer 1975;36(1):203-10.
1975: A H Kuo; X Yataganas; J H Galicich; J Fried; Bayard Clarkson
Proliferative kinetics of central nervous system (CNS) leukemia.
Cancer 1975;36(1):232-9.
1975: M Haghbin; C T Tan; Bayard Clarkson; V Miké; J H Burchenal; M L Murphy
Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Cancer research 1975;35(3):807-11.
1975: X Yataganas; Y Mitomo; F Traganos; A Strife; Bayard Clarkson
Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique.
Acta cytologica 1975;19(1):71-8.
1974: X Yataganas; A Strife; A Perez; Bayard Clarkson
Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine.
Cancer research 1974;34(10):2795-806.
1974: A Polliack; N Lampen; Bayard Clarkson; E De Harven
Scanning electron microscopy of human leukocytes. A comparison of air dried and critical point dried cells.
Israel journal of medical sciences 1974;10(9):1075-85.
1974: J Fried; H Friedman; S Zietz; A Todo; A Strife; Bayard Clarkson
Computer analysis of tracer kinetic data from a human hematopoietic cell line during different phases of growth.
Computers and biomedical research, an international journal 1974;7(4):333-59.
1974: X Yataganas; Bayard Clarkson
Flow microfluorometric analysis of cell killing with cytotoxic drugs.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1974;22(7):651-9.
1974: M Haghbin; C C Tan; Bayard Clarkson; V Miké; J H Burchenal; M L Murphy
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Cancer 1974;33(6):1491-8.
1974: P F Sheehy; T Wakonig-Vaartaja; R Winn; Bayard Clarkson
Asynchronous DNA synthesis and asynchronous mitosis in multinuclear ovarian cancer cells.
Cancer research 1974;34(5):991-6.
1974: B J Lee; G Sahakian; Bayard Clarkson; I H Krakoff
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
Cancer 1974;33(2):533-8.
1974: P F Sheehy; J Fried; R Winn; Bayard Clarkson
Cell cycle changes in ovarian cancer after arabinosylcytosine.
Cancer 1974;33(1):28-37.
1973: A Polliack; N Lampen; Bayard Clarkson; E De Harven; Z Bentwich; F P Siegal; H G Kunkel
Identification of human B and T lymphocytes by scanning electron microscopy.
The Journal of experimental medicine 1973;138(3):607-24.
1973: S Monfardini; T Gee; J Fried; Bayard Clarkson
Survival in chronic myelogenous leukemia: influence of treatment and extent of disease at diagnosis.
Cancer 1973;31(3):492-501.
1973: M D Dowling; M Haghbin; T S Gee; B Cunningham; C T Tan; Bayard Clarkson; J H Burchenal
Comparative results obtained in the treatment of acute leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1973;43():133-44.
1973: Bayard Clarkson; M D Dowling; T S Gee; J H Burchenal
Treatment of acute myeloblastic leukemia.
Bibliotheca haematologica 1973;39():1098-114.
1973: C Tan; M Haghbin; T Gee; Bayard Clarkson; M L Murphy
Combination therapy involving L-asparaginase in acute leukemia.
Bibliotheca haematologica 1973;39():1074-84.
1972: Bayard Clarkson
Acute myelocytic leukemia in adults.
Cancer 1972;30(6):1572-82.
1971: A Todo; A Strife; J Fried; Bayard Clarkson
Proliferative kinetics of human hematopoietic cells during different growth phases in vitro.
Cancer research 1971;31(10):1330-40.
1971: K Ohara; J Fried; M D Dowling; E S Bittar; Bayard Clarkson
Studies on cellular proliferation in human leukemia. VII. Cytokinetic behavior of neoplastic cells in a patient with reticulum cell sarcoma in a leukemic phase.
Cancer 1971;28(4):862-85.
1971: W P Myers; I H Krakoff; Bayard Clarkson
The training of internists in cancer.
The Medical clinics of North America 1971;55(3):647-52.
1971: Bayard Clarkson; J Fried
Changing concepts of treatment in acute leukemia.
The Medical clinics of North America 1971;55(3):561-600.
1971: Bayard Clarkson; E A Boyse
Possible explanation of the high concoddance for acute leukaemia in monozygotic twins.
Lancet 1971;1(7701):699-701.
1971: S C Knight; G E Moore; Bayard Clarkson
Stimulation of autochthonous lymphocytes by cells from normal and leukaemic lines.
Nature: New biology 1971;229(6):185-7.
1970: Bayard Clarkson; A Strife; J Fried; Y Sakai; K Ota; T Ohkita; R Masuda
Studies of cellular proliferation in human leukemia. IV. Behavior of normal hemotopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days.
Cancer 1970;26(1):1-19.
1970: Bayard Clarkson; J Fried; A Strife; Y Sakai; K Ota; T Okita
Studies of cellular proliferation in human leukemia. 3. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days.
Cancer 1970;25(6):1237-60.
1970: M Ogawa; J Fried; Y Sakai; A Strife; Bayard Clarkson
Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia.
Cancer 1970;25(5):1031-49.
1970: Bayard Clarkson; I Krakoff; J Burchenal; D Karnofsky; R Golbey; M Dowling; H Oettgen; A Lipton
Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
Cancer 1970;25(2):279-305.
1970: H F Oettgen; P A Stephenson; Morton K Schwartz; R D Leeper; L Tallai; C C Tan; Bayard Clarkson; R B Golbey; I H Krakoff; D A Karnofsky; M L Murphy; J H Burchenal
Toxicity of E. coli L-asparaginase in man.
Cancer 1970;25(2):253-78.
1970: H F Oettgen; L Tallal; C C Tan; M L Murphy; Bayard Clarkson; R D Golbey; I H Krakoff; D A Karnofsky; H J Burchenal
Clinical experience with L-asparaginase.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1970;33():219-35.
1969: C M Southam; J H Burchenal; Bayard Clarkson; A Tanzi; R Mackey; V McComb
Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats.
Cancer 1969;24(2):211-22.
1969: Bayard Clarkson
Review of recent studies of cellular proliferation in acute leukemia.
National Cancer Institute monograph 1969;30():81-120.
1969: T S Gee; K P Yu; Bayard Clarkson
Treatment of adult acute leukemia with arabinosylcytosine and thioguanine.
Cancer 1969;23(5):1019-32.
1969: Bayard Clarkson; G J Thorbecke; E de Harven; C Miles
Immunoglobulin synthesis by human reticulum sarcoma cells in vivo and during long-term culture in vitro.
Cancer research 1969;29(4):823-36.
1969: C M Southam; J H Burchenal; Bayard Clarkson; A Tanzi; R Mackey; V McComb
Hetero- transplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats.
Cancer 1969;23(2):281-99.
1968: C P Miles; F O'Neill; Donald Armstrong; Bayard Clarkson; J Keane
Chromosome patterns of human leukocyte established cell lines.
Cancer research 1968;28(3):481-90.
1967: H F Oettgen; Lloyd J Old; E A Boyse; H A Campbell; F S Philips; Bayard Clarkson; L Tallal; R D Leeper; Morton K Schwartz; J H Kim
Inhibition of leukemias in man by L-asparaginase.
Cancer research 1967;27(12):2619-31.
1967: Bayard Clarkson
Formal discussion: on the cellular origins and distinctive features of cultured cell lines derived from patients with leukemias and lymphomas.
Cancer research 1967;27(12):2483-8.
1967: J J Van Dyk; Bayard Clarkson; R Duschinsky; O Keller; E La Sala; I H Krakoff
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Cancer research 1967;27(11):2129-36.
1967: Bayard Clarkson; A Strife; E De Harven
Continuous culture of seven new cell lines (SK-L1 to 7) from patients with acute leukemia.
Cancer 1967;20(6):926-47.
1967: E De Harven; Bayard Clarkson; A Strife
Electron microscopic study of human leukemic cells in tissue culture.
Cancer 1967;20(6):911-25.
1967: Bayard Clarkson; T Ohkita; K Ota; J Fried
Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine.
The Journal of clinical investigation 1967;46(4):506-29.
1965: Bayard Clarkson; K Ota; T Ohkita; A O'Connor
Kinetics of proliferation of cancer cells in neoplastic effusions in man.
Cancer 1965;18(10):1189-213.
1965: H J WANEBO; Bayard Clarkson
ESSENTIAL MACROGLOBULINEMIA. REPORT OF A CASE INCLUDING IMMUNOFLUORESCENT AND ELECTRON MICROSCOPIC STUDIES.
Annals of internal medicine 1965;62():1025-45.
1965: Bayard Clarkson; J H BURCHENAL
PROGRESS IN LEUKEMIAS.
Progress in clinical cancer 1965;10():625-63.
1964: Bayard Clarkson
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.
Cancer 1964;17():914-28.
1964: Bayard Clarkson; A KATZ; M A DANN; D A KARNOFSKY
BEHAVIOR OF P388 MOUSE LEUKEMIA IN THE CHICK EMBRYO AND HATCHED CHICK.
Journal of the National Cancer Institute 1964;32():471-95.
1962: S MORI; Bayard Clarkson; A O'CONNOR; W LAWRENCE
Experimental perfusion system utilizing the rabbit Vx-2 carcinoma. III. Correlative studies of in vitro sterilization of Vx-2 cells with results of perfusions in rabbits and in patients.
Clinical pharmacology and therapeutics 1962;3():447-63.
1962: S MORI; Bayard Clarkson; E T MASLE; W LAWRENCE
An experimental perfusion system using the rabbit Vx-2 carcinoma. i. Studies on the effect of drug perfusions and irradiation.
The Journal of surgical research 1962;2():268-82.
1962: Bayard Clarkson; C YOUNG; W DIERICK; P KUEHN; M KIM; A BERRETT; P CLAPP; W LAWRENCE
Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver.
Cancer 1962;15():472-88.
1961: J K DUFF; R D SULLIVAN; E MILLER; A H ULM; Bayard Clarkson; P CLIFFORD
Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
Cancer 1961;14():744-52.
1961: Bayard Clarkson; W LAWRENCE
Perfusion and infusion techniques in cancer chemotherapy.
The Medical clinics of North America 1961;45():689-710.